TUBERCULOUS MENINGITIS
Clinical trials for TUBERCULOUS MENINGITIS explained in plain language.
Never miss a new study
Get alerted when new TUBERCULOUS MENINGITIS trials appear
Sign up with your email to follow new studies for TUBERCULOUS MENINGITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Race to beat brain TB: High-Dose drugs aim to cut treatment time
Disease control Recruiting nowThis study is testing if a new, shorter treatment plan works better for a severe brain infection called tuberculous meningitis (TBM). It will compare a 6-month regimen using higher doses of key drugs against the current standard 9-month treatment. The main goal is to see if the n…
Matched conditions: TUBERCULOUS MENINGITIS
Phase: PHASE2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
Race against time: new drug combo aims to slash deaths from devastating brain infection
Disease control Recruiting nowThis study is testing if adding a drug called adalimumab to the standard treatment can help more people survive a severe brain infection called tuberculosis meningitis when they also have HIV. It will involve 130 adults in Brazil, Mozambique, and Zambia who will receive either th…
Matched conditions: TUBERCULOUS MENINGITIS
Phase: PHASE2 • Sponsor: ANRS, Emerging Infectious Diseases • Aim: Disease control
Last updated Mar 10, 2026 12:52 UTC